NSECredit Rating16 Jul 2026 · 16 Jul 2026, 12:17 pm

Credit Rating

Shilpa Medicare Limited · SHILPAMED

✦ AI SummaryRating Change

Shilpa Medicare Limited has informed the Exchange about Credit Rating revision by India Ratings and Research Pvt Ltd (Fitch Group) for its material subsidiary Shilpa Biologicals Private Limited. The revised ratings are IND A+/Stable/IND A1+ for bank loan facilities.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shilpa Medicare Limited has informed the Exchange about Credit Rating

Attachments (1)

📄

SHILPAMED_16072026121619_SBPL_credit_rating.pdf

pdf

Download →
View document text
Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 16 July 2026 Corporate Relationship Department, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Stock Code: NSE: SHILPAMED/BSE-530549 Dear Sir/Madam, Sub: Intimation of Revision in Credit Rating of Shilpa Biologicals Private Limited, a Material Subsidiary of Shilpa Medicare Limited by India Ratings and Research Pvt Ltd (Fitch Group) Pursuant to Regulations 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Regulation’), please find below the details of the revision in credit rating issued by India Ratings and Research Pvt. Ltd (Fitch Group) for Shilpa Biologicals Private Limited, a Material Subsidiary of Shilpa Medicare Limited: The instrument-wise ratings are given below: Shilpa Biologicals Private Limited Instrument Regulator of Size of Issue Rating assigned along with Rating Action Type Instruments (million) Outlook/ Watch Bank loan RBI INR1,250 IND A+/Stable/IND A1+ Assigned facilities The said rating is available on the website: https://www.indiaratings.co.in/pressrelease/vvcjm5z7lelcs9xccylo0oms This is for your information and records. For SHILPA MEDICARE LIMITED Ritu Tiwary Company Secretary & Compliance Officer